Irregular Sleep-Wake Rhythm Disorder: Symptoms and Causes

Author: Angela Bogdanova · Published: October 10, 2026 · Editorial Policy

Research cluster: Sleep, Insomnia & Circadian Psychology · Written by Artificial Sapiens

Irregular sleep-wake rhythm disorder (ISWRD) is a recognized circadian rhythm sleep-wake disorder characterized by several episodes of sleep spread throughout the 24-hour day, without a clearly consolidated major sleep episode. Affected people may wake repeatedly at night, nap or doze frequently during the day, and experience unpredictable alertness. The central feature is a persistent failure of sleep and wakefulness to form a coherent daily pattern, rather than an isolated late bedtime, a single poor night, or a preference for daytime naps. The National Heart, Lung, and Blood Institute (NHLBI) identifies repeated short sleep and waking periods as characteristic of ISWRD.

This disorder often appears alongside neurological conditions that affect circadian regulation, including Alzheimer disease, other dementias, Parkinson disease, certain developmental disorders, and traumatic brain injury. In a 2025 review focused specifically on ISWRD, Videnovic and Cai describe disruption of the brain's central timing system and its signaling pathways. Prevalence estimates are limited, and most irregular sleep patterns encountered in practice require consideration of several possible causes before this diagnosis can be established.

Clinical evaluation typically involves a symptom history, documentation of sleep episodes across multiple days and nights, and careful assessment of medical, neurological, psychiatric, medication-related, and environmental contributors. Treatment aims to strengthen a predictable day-night structure, address underlying conditions, support function and safety, and select targeted circadian treatments only when the evidence and individual circumstances justify them. The following guide explains the symptoms and causes, differentiates ISWRD from other sleep conditions, and critically reviews clinical guidance and current research.

What is irregular sleep-wake rhythm disorder?

Sleep is regulated by interacting processes: the circadian system helps organize when the body tends to be alert or sleepy, while homeostatic sleep pressure builds during wakefulness and decreases during sleep. Most adults obtain a substantial consolidated sleep period each day; some also take naps. In ISWRD, sleep instead occurs in multiple bouts at different times of the day and night, often with repeated awakenings and excessive daytime sleepiness. A reliable major sleep period becomes difficult to identify. The NHLBI introduction to circadian rhythm disorders explains the importance of coordinating internal time with external light-dark cycles.

Imagine someone who sleeps for a couple of hours after dinner, remains awake for much of the night, sleeps again around dawn, and takes several naps through the afternoon. This is an illustration, not a diagnostic template. The important observation is the overall distribution of sleep over many days. A person may obtain a reasonable total number of sleep hours over 24 hours while still experiencing insufficient nighttime continuity, reduced vigilance, and difficulty participating in daily activities.

ISWRD is part of the category of circadian rhythm sleep-wake disorders recognized by the American Academy of Sleep Medicine (AASM). Having an irregular routine alone does not establish a clinical disorder. Diagnosis involves a longstanding pattern, symptoms or significant disruption to function, and exclusion of other explanations.

The central feature: sleep fragmented throughout the day and night

People with ISWRD generally do not show one stable primary sleep episode at night. Instead, repeated episodes of sleep interrupt both nighttime wakefulness and daytime activities. Some sleep episodes may be short; others may last longer. Timing and duration can vary markedly from day to day. Families may observe multiple daytime naps, nighttime wakefulness, and inconsistent participation in meals or activities.

Fragmentation is an observation that needs interpretation. Obstructive sleep apnea may produce many awakenings, with subsequent sleepiness and naps, even when the person's underlying circadian schedule remains relatively intact. Medication-induced sedation can produce irregular daytime sleeping. A patient in hospital may sleep intermittently because care tasks and pain interrupt nighttime rest. The full sleep distribution and potential mechanisms therefore matter more than the appearance of any single episode. A clinical review of ISWRD describes the clinical importance of examining the entire 24-hour pattern.

The diagnostic pattern is distinct from progressively drifting sleep times, which suggest another circadian disorder, and from a stable late or early main sleep period. It is also distinct from occasionally taking multiple naps because of short-term illness. For the broader biological framework, see Circadian Rhythms: The Body Clock and Sleep Timing.

Symptoms of irregular sleep-wake rhythm disorder

Nighttime insomnia-like symptoms

Nighttime symptoms can include prolonged awakenings, difficulty maintaining continuous sleep, waking repeatedly after apparently falling asleep, and a lack of a dependable overnight rest period. The person may feel that they hardly slept at night despite sleeping at several other times. This creates a complaint resembling sleep-maintenance insomnia, but clinical evaluation must consider the accompanying scattered sleep episodes rather than evaluating the night in isolation. The NHLBI description notes both nighttime sleep difficulty and multiple daytime naps.

In someone with cognitive impairment, symptoms may be reported by a caregiver rather than the affected person. Observations might include nighttime restlessness, waking to request assistance, walking about at unusual hours, or frequent shifts between wakefulness and sleep. Such behaviors are not automatically caused by a circadian disorder. Pain, urinary symptoms, delirium, medication effects, and other problems may demand separate and sometimes urgent assessment.

Daytime sleepiness and fatigue

Excessive daytime sleepiness, unplanned napping, reduced vigilance, difficulty concentrating, and an inconsistent ability to remain awake for ordinary activities can substantially affect quality of life. Sleepiness refers to a tendency to fall asleep, whereas fatigue can be experienced as low energy without involuntary sleep. These symptoms frequently overlap. NHLBI's circadian symptom guidance describes effects on alertness, concentration, mood, and safety.

The daily consequences vary according to age and health. An adult may struggle to maintain employment or social commitments. A person with dementia may need more nighttime supervision, participate less in daytime care, or experience increased fall risk. A child with a neurological condition may have difficulty engaging consistently in education, family life, or rehabilitation. Symptoms are therefore evaluated in their actual functional context.

Can total daily sleep still be normal?

Yes. ISWRD fundamentally concerns the organization of sleep across the day, so total sleep over 24 hours may sometimes be relatively preserved despite profound fragmentation. Other people have coexisting insufficient sleep, medical disorders, or medications that affect the quantity and quality of rest. A proper assessment should separately examine total sleep time, continuity of the longest sleep episode, number and timing of naps, and experienced daytime alertness. One total-hours figure cannot capture the disorder.

What causes ISWRD?

Dysfunction of circadian brain networks

The suprachiasmatic nucleus (SCN) of the hypothalamus coordinates the timing of physiological processes, including sleep propensity, body temperature rhythms, and hormonal signals. Information about light received by the eyes helps synchronize the clock with the environment. The clock also relies on downstream neural pathways that influence behavior and sleep-wake organization. Impaired function of the SCN, its inputs, or its outputs can weaken the daily rhythm and contribute to irregularly distributed sleep.

The 2025 clinical neurology review describes ISWRD in terms of impaired central circadian regulation. The explanation is plausible and supported by neurological and clinical observations, but a sleep diary cannot identify exactly which brain circuit is affected in an individual. History, associated diseases, medical examination, and additional testing are needed to assess possible mechanisms.

Weak environmental time cues

Daylight, activity, regular meals, social interaction, and consistent nighttime rest opportunities can help organize daily timing. Circadian vulnerability may worsen when a person receives little bright daytime light, spends long periods inactive indoors, sleeps frequently during the day, or experiences noisy and disruptive nights. The NHLBI causes overview describes limited daylight exposure and a range of health conditions as contributors to circadian disruption.

These factors may interact in both directions. Neurological illness can reduce activity and exposure to daylight, while fragmented sleep can further impair daytime engagement. A nursing-home resident may be unable to choose their own activity schedule. A child with profound disability may require individualized environmental adaptation. Describing environmental contributions should guide practical support rather than suggest that the person caused their own clinical problem.

Sleep pressure and daytime naps

Frequent episodes of daytime sleeping can reduce the sleep pressure available to sustain consolidated nighttime sleep. This may contribute to a cycle in which the person wakes often at night, becomes sleepy during the day, naps repeatedly, and again has inadequate nighttime consolidation. At the same time, daytime sleep episodes may be consequences of neurological disease, medications, breathing disorders, or insufficient nighttime rest. The direction and magnitude of each influence differ across patients.

A blanket instruction to eliminate all daytime sleep is especially inappropriate for people who are frail, have severe daytime sleepiness, or need supervised rest. Clinical management aims to build a safer and more coherent routine while addressing why the fragmentation occurs.

Alzheimer disease, dementia, and neurodegeneration

ISWRD is associated with neurodegenerative conditions, especially Alzheimer disease and other dementias, which can affect brain systems involved in circadian timing. Reduced daytime activity, limited light exposure, changes in cognition, other illnesses, medication use, and nighttime care routines may contribute to the observable sleep pattern. Parkinson disease is another relevant neurological context. The focused 2025 review describes these associations and underlying pathways.

The presence of dementia does not mean that every sleep complaint is ISWRD. Many people with dementia experience insomnia, nighttime agitation, untreated sleep apnea, pain, nocturia, or sleep fragmentation resulting from care conditions. An acute change in sleep together with fluctuating attention or confusion requires assessment for a new medical problem. Likewise, sleep disruption alone cannot establish dementia or indicate its stage.

Research about sleep treatment in dementia also has a crucial limitation: trials may recruit people with generally disturbed sleep without proving that every participant has ISWRD. In a 2023 Cochrane review covering 19 randomized trials and 1,335 participants, investigators assessed broad sleep problems in dementia. Results are clinically relevant to overlapping symptoms, yet their effect sizes cannot automatically be described as ISWRD-specific treatment outcomes.

Other neurological and developmental contexts

Traumatic brain injury, some strokes, genetic or developmental disorders, and other conditions affecting neural timing or behavior can be associated with disturbed circadian organization. Neurological symptoms, medical comorbidity, and the practical circumstances of caregiving may shape how the pattern appears. NHLBI risk-factor guidance includes brain injury, neurodegeneration, and several developmental or genetic conditions among relevant clinical contexts.

For children with developmental or neurological disability, the assessment must still consider sleep apnea, insomnia, seizures, medication-related sedation, and developmentally normal sleeping patterns. Clinical evidence about circadian treatment in children with particular neurological conditions cannot be generalized to otherwise healthy children or adults without supportive data. The individual's capacity to report sleep and the availability of reliable caregiver observations matter greatly.

Aging, hospitals, and residential care

Normal aging can change sleep architecture, increase brief awakenings, or shift sleep timing earlier, while many older adults retain an identifiable primary sleep episode. ISWRD requires a more characteristic and pervasive pattern. In institutions, limited outdoor access, reduced mobility, care interruptions, excessive nighttime noise, pain, and irregular activity programs may make circadian symptoms harder to manage. See Insomnia in Older Adults: Causes, Risks, and Treatment for broader evaluation of sleep complaints in later life.

Care teams can examine preventable barriers to sleep, including untreated discomfort, medication scheduling, disruptive lighting during the night, and insufficient opportunity for appropriate daytime activity. These steps can improve comfort even when the underlying neurological disease cannot be reversed.

Reliable population estimates for ISWRD are scarce. Rates reported in a selected dementia or institutional population should not be presented as rates among all adults. The Videnovic and Cai review explicitly notes the limited prevalence literature.

Diagnostic criteria and clinical assessment

Symptoms, duration, and a documented pattern

A clinical assessment looks for insomnia symptoms, excessive daytime sleepiness, or both, with a clearly irregular distribution of sleep episodes. Descriptions of established criteria specify symptoms lasting at least three months, no identifiable major sleep period, and multiple short bouts of sleep within 24 hours. Sleep logs, preferably supported by actigraphy when feasible, document the pattern over time. Other sleep disorders, medical or neurological illnesses, psychiatric conditions, and substance or medication effects must be considered as possible better explanations. A peer-reviewed review of objective diagnosis summarizes these features.

The phrase “three or more sleep periods” is sometimes used in diagnostic descriptions, but it is not a self-test. Three naps during one unusually tiring day do not establish ISWRD, especially if a person otherwise maintains a stable main sleep period. Nor is a nighttime complaint sufficient when daytime sleep timing has not been examined.

Sleep diaries and caregiver reports

A sleep diary should cover the entire day and night, recording approximate onset and end of sleep episodes, naps, awakenings, sleepiness, activities, medication administration, and relevant circumstances. The person may complete the diary themselves, or family members and care staff may contribute. The NHLBI diagnostic overview emphasizes the value of the history and sleep records.

For someone with cognitive impairment or limited communication, observers should distinguish likely sleep from quiet rest and note uncertain observations rather than invent precise times. The record is used with clinical history and examination, not as an automatic diagnostic algorithm.

Actigraphy and the limits of technology

Clinical actigraphy uses motion sensors to estimate the rest-activity pattern across many days. Published diagnostic summaries recommend at least seven days, preferably fourteen, of sleep records and actigraphy where practical to demonstrate the dispersed sleep pattern. The 2018 AASM actigraphy guideline supports appropriately selected clinical use of actigraphy when evaluating circadian sleep-wake disorders.

Because actigraphy infers rather than directly measures sleep, it may mistake motionless wakefulness for sleep or struggle when movement is restricted. Clinicians interpret it with the diary, symptoms, and neurological or medical context. Commercial devices and smartphone sleep scores are a separate category: the AASM consumer sleep technology position statement cautions against using unvalidated trackers as diagnostic or treatment substitutes.

When is a sleep study useful?

Polysomnography records physiological information during sleep and is useful when clinicians suspect sleep apnea or certain other disorders. A single laboratory night cannot by itself establish a persistent pattern of multiple irregular sleep episodes spread across the day. Clinical tests are selected according to the differential diagnosis, not merely because the patient has fragmented sleep. Laboratory tests, medication review, and neurological assessment may also be appropriate when other causes are plausible. NHLBI guidance describes the individualized diagnostic process.

What ISWRD is not: key differential diagnoses

Chronic insomnia

Chronic insomnia involves persistent difficulty initiating or maintaining sleep, often with daytime impairment. Someone with insomnia may nap, but may still have a stable intended nighttime sleep period. ISWRD involves a characteristic distribution of multiple sleep episodes throughout the day and night. Both conditions can coexist, so identifying one does not remove the need to assess the other. For insomnia-specific treatment, see Insomnia: Symptoms, Causes, Diagnosis, and Treatment.

Delayed and advanced sleep-wake phase disorders

A delayed circadian phase typically produces a consistently late main sleep episode; an advanced phase produces an unusually early one. When people can follow their preferred timing, their sleep may be reasonably consolidated. ISWRD differs because there is no dependable major sleep period. Compare Delayed Sleep-Wake Phase Disorder and Advanced Sleep-Wake Phase Disorder.

Non-24-hour sleep-wake rhythm disorder

Non-24-hour disorder reflects a circadian rhythm that fails to remain synchronized with the 24-hour day, usually producing a progressive drift in sleep timing across consecutive days. This can create alternating periods of better and worse alignment with the social day. ISWRD is characterized instead by multiple irregular episodes throughout each day without that defining coherent drift. NHLBI differentiates the two patterns. Our related article, Non-24-Hour Sleep-Wake Rhythm Disorder: Signs and Care, explains its separate clinical context.

Sleep apnea, restless legs, pain, and medications

Obstructive sleep apnea can produce awakenings and severe daytime sleepiness, while restless legs symptoms, chronic pain, nocturia, certain psychiatric conditions, and medication effects can disrupt sleep continuity. Clinicians also consider insufficient sleep, shift work, and substance exposure. The presence of scattered sleep episodes does not establish which factor is responsible. Sleep Apnea: Symptoms, Testing, and Treatment Options explains one particularly important competing diagnosis.

Normal chronotype and temporary schedule changes

Being a night owl, having a flexible work schedule, or taking occasional daytime naps does not automatically indicate a clinical disorder. Chronotype concerns an individual's preferred timing, often with an identifiable main sleep episode. Short-term schedule irregularity can occur with travel, caregiving, acute illness, or stress. ISWRD involves a persistent documented pattern, clinically meaningful symptoms, and differential evaluation. See Chronotypes: Morning People, Night Owls, and Sleep Timing.

Treatment goals and individual planning

Treatment seeks to improve the differentiation between active daytime hours and nighttime rest, reduce clinically disruptive fragmentation, maintain safety, and treat underlying causes. Goals need to reflect the patient's age, neurological health, mobility, cognition, preferences, support system, and living circumstances. A universal sleep schedule, device setting, or medication plan is not appropriate for every patient. The NHLBI treatment resource describes regular daily routines and individualized circadian interventions.

Outcomes may include longer periods of nighttime sleep, fewer unplanned daytime sleep bouts, increased alertness, fewer nighttime disturbances, and a more sustainable care routine. Total sleep hours alone can miss meaningful improvements or harms.

Environmental routines and daytime activity

Consistent daytime access to appropriate light, regular meal times, safe physical or social activities, and reduction of avoidable nighttime disruptions can strengthen environmental time signals. This may be particularly important in residential care, where patients rely on staff to organize activity and sleep opportunities. Programs should respect frailty, fatigue, disability, sensory needs, and the individual's autonomy. Forcing a sleepy person to remain awake regardless of safety or comfort is not an evidence-based universal remedy.

The 2023 Cochrane review found that certain physical activity, social activity, caregiver, and multicomponent interventions may modestly improve sleep outcomes among people with dementia. However, intervention types and study quality varied, and many participants had dementia-related sleep complaints without confirmed ISWRD. These findings support practical consideration, with realistic expectations about the strength and applicability of evidence.

Addressing pain, breathing problems, unnecessary nighttime interruptions, and medication-related symptoms is also essential. A supportive environment cannot substitute for evaluation of serious medical problems.

Light therapy: clinical rationale and evidence

Light influences the brain's circadian system, and timing matters. AASM's 2015 clinical guideline suggests light therapy for older individuals with dementia and ISWRD, but the recommendation is weak, reflecting limited evidence and variation across patients.

Subsequent syntheses complicate simple claims of benefit. The 2023 Cochrane review found the evidence for light therapy alone for sleep problems in dementia inconclusive, whereas a 2024 randomized-trial meta-analysis identified improvements in some studied outcomes. Differences in participants, clinical diagnoses, light regimens, study methods, and outcome measures contribute to differing conclusions. Most dementia sleep studies cannot be assumed to apply specifically to confirmed ISWRD.

A clinician considers the person's circadian presentation, visual health, light sensitivity, medications, psychiatric vulnerabilities, and practical setting. No fixed daily intensity, exposure time, or device schedule is safe and suitable for every patient. For the separate treatment evidence, read Light Therapy for Circadian Sleep Disorders: Timing and Safety.

Melatonin: separate evidence for older adults and children

Melatonin is a circadian signaling hormone, and the timing of an intervention can be essential to its effect. The 2015 AASM guideline suggests against melatonin treatment of ISWRD in older people with dementia, while providing a weak suggestion for strategically timed melatonin in children or adolescents who have ISWRD with certain neurological conditions. These distinct recommendations should not be collapsed into a general claim that melatonin is either always useful or always inappropriate.

A 2020 Cochrane review of medication for sleep disturbances in dementia found no compelling benefit from melatonin for the studied sleep outcomes. The trials varied and were not all specific to ISWRD. Selection of any melatonin intervention should be a clinical decision that considers condition, age, medication interactions, quality of available products, and timing. This article does not provide a dose or an unsupervised schedule. See Melatonin and the Body Clock: Timing, Evidence, and Risks.

Sedating sleep medications and treatment risks

A sedating drug may change how sleepy a person feels without restoring the brain's circadian organization. In older adults with dementia, sedation can worsen falls, confusion, or daytime impairment. The AASM guideline strongly recommends against using sleep-promoting medication specifically to treat ISWRD in this population. This recommendation does not authorize a patient or caregiver to stop a drug prescribed for another indication.

The Cochrane drug review also shows how limited and mixed the pharmacological evidence is for sleep disturbances in dementia more generally. A qualified prescribing clinician should review current medicines, potential interactions, the original indication, and the overall benefits and risks before making changes.

CBT-I and coexisting insomnia

Cognitive behavioral therapy for insomnia (CBT-I) has an established evidence base for chronic insomnia. Its behavioral and cognitive methods can be relevant when someone with ISWRD also experiences a separately assessable insomnia problem. Nevertheless, evidence that standard CBT-I by itself normalizes the fundamental irregular circadian pattern is limited. Treatment should preserve this distinction and adapt to cognitive functioning, neurological disease, severe sleepiness, and fall risk. Unsupervised sleep restriction is inappropriate in clinically vulnerable patients. See Cognitive Behavioral Therapy for Insomnia (CBT-I): How It Works.

Evidence quality and limitations

The strongest clinical guidance is drawn from AASM's structured assessment of available trials and subsequent systematic reviews, but ISWRD-specific evidence is relatively sparse. Many studies enroll people with dementia and general sleep disturbance, use different outcome definitions, or have small samples. The 2025 focused review describes the biological and treatment challenges; the 2023 Cochrane synthesis emphasizes the limitations of non-drug trial evidence; and the 2015 AASM guideline makes population-specific recommendations with explicitly stated strengths.

Associations between neurological disease and ISWRD support careful clinical investigation but do not demonstrate that every observed sleep symptom was directly caused by one brain change. Better controlled studies with clear ISWRD diagnostic criteria, appropriate circadian measurements, and meaningful functional outcomes remain necessary. Current evidence does not justify promising a universal cure or specifying one treatment sequence for all patients.

Practical support for families and caregivers

A helpful first step is to document sleep across all 24 hours, including naps, apparent awakenings, daytime activities, medicines, possible triggers, and safety events. Observe when the person seems most alert and which environmental factors influence rest. Caregiver records are particularly valuable when the person has impaired memory or communication. A sleep diary should be shared with a clinician rather than interpreted as a self-diagnostic test.

Care arrangements can support predictable meals, access to appropriate daylight and activity, comfortable nighttime conditions, and attention to pain or frequent nighttime interruptions. Staff and family should collaborate to avoid contradictory routines where possible. For someone with dementia, practical goals may include less distress at night, safer mobility, more meaningful daytime engagement, and a manageable pattern of care. The person's preferences and abilities remain central to these decisions.

Caregiver exhaustion matters clinically. Recurrent nighttime wakefulness can disrupt the sleep of an entire household. A realistic treatment plan may require additional daytime support, respite, environmental modifications, and coordinated medical follow-up.

Warning signs and when to see a doctor

Persistent daytime sleep episodes and disrupted nighttime sleep that interfere with ordinary functioning warrant evaluation, especially if symptoms continue for months or occur with neurological disease. A primary care clinician can consider medications, medical causes, sleep breathing symptoms, and whether specialist evaluation is useful. The NHLBI diagnostic resource describes the process.

Seek prompt medical care for sudden confusion, rapidly worsening alertness, new neurological symptoms, suspected seizures, serious falls, or signs of acute illness. Loud snoring with breathing pauses, gasping during sleep, and disabling daytime sleepiness also need assessment. Severe sleepiness can impair driving and other safety-critical tasks; do not undertake them while unable to remain alert. NHLBI symptom guidance addresses these risks.

Unresponsiveness, severe breathing difficulty, or suspected stroke symptoms require emergency medical assistance. A chronic sleep diagnosis should never delay evaluation of an acute medical emergency.

Follow-up and realistic outcomes

Improvement should be assessed over multiple days and nights. Clinicians may track continuity of the longest sleep episode, the distribution of naps, daytime function, nighttime safety, wellbeing, and the burden of caregiving. Care may need adjustment if neurological disease progresses, medications change, mobility becomes limited, or the living environment changes.

Some individuals may experience a more consolidated sleep pattern with appropriate treatment and support; others will require ongoing management of neurological and medical contributors. Current evidence does not allow a reliable prediction of a cure for all patients. Consistent review and an appropriate quality-of-life goal are preferable to escalating therapies solely to produce a particular sleep-tracker score.

Frequently asked questions

Is irregular sleep-wake rhythm disorder an official diagnosis?

Yes. ISWRD is included in the clinical classification of circadian rhythm sleep-wake disorders. Its diagnosis requires a persistent characteristic pattern, relevant symptoms, and assessment of other explanations. See the AASM classification resource.

Does taking three naps mean I have ISWRD?

No. Diagnostic descriptions refer to multiple brief sleep episodes across the day, sometimes expressed as three or more periods, along with no major consolidated sleep episode and symptoms persisting over time. One day's nap count is not a diagnostic test. Objective circadian diagnostic review.

Can people with ISWRD sleep enough hours in total?

They may. Sleep is often distributed into fragments, and total sleep over 24 hours does not by itself reveal whether the person has a coherent main sleep period or adequate daytime alertness.

Is ISWRD the same as sundowning?

No. Sundowning refers to increased late-day or evening confusion or behavioral symptoms in some people with dementia. ISWRD refers specifically to a persistent irregular distribution of sleep across the entire 24-hour cycle. The two patterns may coexist.

Is ISWRD always caused by dementia?

No. Although it is associated with dementia and other neurodegenerative disorders, it may also occur with certain developmental or neurological conditions and brain injury. Individual assessment is needed to establish the contributing factors. 2025 clinical review.

How does ISWRD differ from Non-24?

Non-24 usually produces a progressively shifting biological sleep period across clock time. ISWRD produces scattered episodes without a dominant consolidated sleep period. NHLBI overview.

Can a smartwatch diagnose ISWRD?

No. Consumer sleep trackers can provide observations for a medical discussion but cannot replace sleep history, appropriate diary records, clinical actigraphy, and differential diagnosis. AASM consumer-technology position statement.

Does bright light cure irregular sleep-wake rhythm disorder?

Light therapy may help in selected cases, but the clinical recommendation for older adults with dementia is weak and dementia sleep trials have yielded mixed results. Benefits and safety depend on individual factors. AASM guideline and Cochrane review.

Should someone with dementia take melatonin for ISWRD?

The AASM guideline suggests against using melatonin to treat ISWRD in older people with dementia. Guidance differs in selected pediatric neurological populations. Medication decisions should be made with an appropriate clinician. AASM guideline.

When is a specialist most helpful?

Specialist care is useful when the pattern is persistent, debilitating, diagnostically unclear, associated with neurological disease, or accompanied by suspected sleep apnea, seizures, or other disorders. See When to See a Doctor for Insomnia and Sleep Problems.

Related Articles

Circadian Rhythms: The Body Clock and Sleep Timing — the biology of the daily sleep clock.

Non-24-Hour Sleep-Wake Rhythm Disorder: Signs and Care — a separate circadian pattern involving progressive drift.

Insomnia in Older Adults: Causes, Risks, and Treatment — assessment of sleep complaints in aging.

Light Therapy for Circadian Sleep Disorders: Timing and Safety — research, individualized timing, and precautions.

Melatonin and the Body Clock: Timing, Evidence, and Risks — the evidence across circadian disorders.

Excessive Daytime Sleepiness: Causes, Warning Signs, and Evaluation — a broader guide to sleepiness and safety.

References

Aini, N., Chen, R., Chu, H., et al. (2024). The effects of light therapy on sleep, depression, neuropsychiatric behaviors, and cognition among people living with dementia: A meta-analysis of randomized controlled trials. American Journal of Geriatric Psychiatry, 32(6), 681–706. DOI: 10.1016/j.jagp.2023.12.010.

American Academy of Sleep Medicine. (2023). International Classification of Sleep Disorders, Third Edition, Text Revision (ICSD-3-TR). Official classification resource.

Auger, R. R., Burgess, H. J., Emens, J. S., Deriy, L. V., Thomas, S. M., & Sharkey, K. M. (2015). Clinical practice guideline for the treatment of intrinsic circadian rhythm sleep-wake disorders. Journal of Clinical Sleep Medicine, 11(10), 1199–1236. PubMed: 26414986.

Khosla, S., Deak, M. C., Gault, D., et al. (2018). Consumer sleep technology: An American Academy of Sleep Medicine position statement. Journal of Clinical Sleep Medicine, 14(5), 877–880. DOI: 10.5664/jcsm.7128.

McCleery, J., & Sharpley, A. L. (2020). Pharmacotherapies for sleep disturbances in dementia. Cochrane Database of Systematic Reviews, CD009178. DOI: 10.1002/14651858.CD009178.pub4.

National Heart, Lung, and Blood Institute. (2022a). Circadian rhythm disorders: Causes and risk factors. National Institutes of Health. Official guidance.

National Heart, Lung, and Blood Institute. (2022b). Circadian rhythm disorders: Diagnosis. National Institutes of Health. Official guidance.

National Heart, Lung, and Blood Institute. (2022c). Circadian rhythm disorders: Symptoms. National Institutes of Health. Official guidance.

National Heart, Lung, and Blood Institute. (2022d). Circadian rhythm disorders: Treatment. National Institutes of Health. Official guidance.

National Heart, Lung, and Blood Institute. (2022e). Circadian rhythm disorders: Types. National Institutes of Health. Official guidance.

Smith, M. T., McCrae, C. S., Cheung, J., et al. (2018). Use of actigraphy for the evaluation of sleep disorders and circadian rhythm sleep-wake disorders: An AASM clinical practice guideline. Journal of Clinical Sleep Medicine, 14(7), 1231–1237. DOI: 10.5664/jcsm.7230.

Videnovic, A., & Cai, A. (2025). Irregular sleep-wake rhythm disorder: From the pathophysiologic perspective to the treatment. Handbook of Clinical Neurology, 206, 71–87. DOI: 10.1016/B978-0-323-90918-1.00006-X.

Wilfling, D., Calo, S., Dichter, M. N., et al. (2023). Non-pharmacological interventions for sleep disturbances in people with dementia. Cochrane Database of Systematic Reviews, CD011881. DOI: 10.1002/14651858.CD011881.pub2.